BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12138137)

  • 1. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
    Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
    J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.
    Schumacher VA; Jeruschke S; Eitner F; Becker JU; Pitschke G; Ince Y; Miner JH; Leuschner I; Engers R; Everding AS; Bulla M; Royer-Pokora B
    J Am Soc Nephrol; 2007 Mar; 18(3):719-29. PubMed ID: 17267748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
    Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
    Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1.
    Viney RL; Morrison AA; van den Heuvel LP; Ni L; Mathieson PW; Saleem MA; Ladomery MR
    Proteomics; 2007 Mar; 7(5):804-15. PubMed ID: 17295355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin.
    Palmer RE; Kotsianti A; Cadman B; Boyd T; Gerald W; Haber DA
    Curr Biol; 2001 Nov; 11(22):1805-9. PubMed ID: 11719225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
    Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
    Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
    Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
    Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of renal EGF receptor expression is normal in Denys-Drash syndrome.
    Vicanek C; Ferretti E; Goodyer C; Torban E; Moffett P; Pelletier J; Goodyer P
    Kidney Int; 1997 Sep; 52(3):614-9. PubMed ID: 9291179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
    Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.
    Swiatecka-Urban A; Mokrzycki MH; Kaskel F; Da Silva F; Denamur E
    Pediatr Nephrol; 2001 Aug; 16(8):627-30. PubMed ID: 11519891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) syndrome.
    Dahan K; Kamal M; Noël LH; Jeanpierre C; Gubler MC; Brousse N; Mariaud de Serre NP
    Am J Kidney Dis; 2007 Jun; 49(6):793-800. PubMed ID: 17533022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denys-Drash syndrome with neonatal renal failure in monozygotic twins due to c.1097G>A mutation in the WT1 gene.
    Furtado LV; Pysher T; Opitz J; Lamb R; Comstock J; Batish S; Mauch T; Nelson R; Zhou H
    Fetal Pediatr Pathol; 2011; 30(4):266-72. PubMed ID: 21434831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
    Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.
    Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V
    Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
    Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
    J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).
    Patek CE; Brownstein DG; Fleming S; Wroe C; Rose L; Webb A; Berry RL; Devenney PS; Walker M; Maddocks OD; Lawrence NJ; Harrison DJ; Wood KM; Miles CG; Hooper ML
    Transgenic Res; 2008 Jun; 17(3):459-75. PubMed ID: 18040647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.